financetom
Business
financetom
/
Business
/
Why Did Expion360 (XPON) Shares Jump 42% After Hours?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Did Expion360 (XPON) Shares Jump 42% After Hours?
Mar 11, 2026 2:05 AM

Expion360 Inc. ( XPON ) shares rose 41.97% in after-hours trading on Wednesday to $1.28, after the lithium battery manufacturer announced preliminary, unaudited financial results for the year ended December 31, 2025.

According to Benzinga Pro data, XPON closed the regular session at $0.90, up 5.33%.

Revenue Nearly Doubles Year-Over-Year

Expion360 ( XPON ) reported year-over-year improvements across key financial metrics:

Metric2025 (Preliminary Unaudited)2024Change
Revenue $9.6 million $5.6 million Up $4.0 million
Gross Profit $2.2 million $1.2 million Up $1.0 million
Cash Balance $3.0 million $0.5 million Up $2.5 million

The company also noted that the preliminary unaudited net loss is expected to be approximately $6.2 million, compared to a net loss of $13.5 million in 2024.

Expansion Plans for 2026

Joseph Hammer, Chief Executive Officer of Expion360 ( XPON ), said, “We continue to make progress in our growth strategy, delivering revenue growth, improving gross margins, and strengthening our balance sheet.”

Hammer further added that new initiatives for 2026 include expansion into the industrial and construction sectors, development of specialized energy storage solutions for surveillance and monitoring applications, and the implementation of a technology improvement roadmap to broaden the portfolio and add new revenue streams.

The preliminary results are subject to completion of year-end accounting procedures and audit of the company’s financial statements.

Trading Metrics, Technical Analysis

The Relative Strength Index (RSI) of XPON stands at 49.06.

The stock of the Oregon-based company has a market capitalization of $8.67 million, with a 52-week high of $5.50 and a 52-week low of $0.60.

Over the past 12 months, Expion360 ( XPON ) stock has fallen 41.83%, marking a difficult year for the company.

Currently, the stock is positioned at 6.12% of its annual range, indicating it is closer to its lows than its highs.

This annual decline and weak positioning reflect a significant loss of investor confidence and suggest that the stock is struggling to find stable footing.

Benzinga's Edge Stock Rankings indicate that XPON has a negative price trend across all time frames.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company , and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combi
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company , and Denali Capital Acquisition Corp. Announced the Closing of Their Previously Announced Business Combi
Sep 23, 2025
Semnur’s shares of common stock and warrants are expected to trade on the OTC Markets on September 23, 2025 under the ticker symbols “SMNR” and “SMNRW”, respectively.Scilex (together with its affiliates) owns approximately 87.5% of Semnur common stock post Business Combination PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR, SMNRW)...
J&J to withdraw acid reflux device from non-US markets, Bloomberg News reports
J&J to withdraw acid reflux device from non-US markets, Bloomberg News reports
Sep 23, 2025
(Reuters) -Johnson & Johnson ( JNJ ) will withdraw a device to treat acid reflux disease from markets outside the U.S., Bloomberg News reported on Tuesday, citing a company letter sent to doctors. The company has decided to withdraw the product, called LINX Reflux Management System, from March for commercial reasons, and not due to safety or efficacy issues, the...
UBS to Pay $986 Million to Resolve Legacy French Tax Case
UBS to Pay $986 Million to Resolve Legacy French Tax Case
Sep 23, 2025
05:41 AM EDT, 09/23/2025 (MT Newswires) -- UBS Group ( UBS ) said Tuesday it has agreed to pay 835 million euros ($985.8 million) to resolve the legacy tax matter pertaining to its cross-border business activities in France between 2004 and 2012. The Swiss banking giant will pay a fine of 730 million euros and 105 million euros in civil...
Update: Firefly Aerospace Q2 Loss Widens, Revenue Falls; Shares Down Pre-Bell
Update: Firefly Aerospace Q2 Loss Widens, Revenue Falls; Shares Down Pre-Bell
Sep 23, 2025
05:47 AM EDT, 09/23/2025 (MT Newswires) -- (Updates with the latest stock price movement in the headline and the first paragraph.) Firefly Aerospace ( FLY ) shares were down nearly 13% in recent premarket activity Tuesday after the company's Q2 loss widened year over year and its revenue fell. The company reported a Q2 net loss late Monday of $5.78...
Copyright 2023-2026 - www.financetom.com All Rights Reserved